All achieved results from studies of plasma TIMP-1 and CEA [61,62,66] are comparable with the emerging results of Septin 9 (SEPT9) regarding sensitivity and specificity for CRC detection. The gene discussed is CEACAM5; the disease is colorectal carcinoma.